Market Place
Sourcing Support
Lucence Announces Medicare Reimbursement Decision for LiquidHALLMARK Assay
22 Feb 2023 //
BUSINESSWIRE
Lucence Presents Data at WCLC Supporting Utility of Amplicon-Based Liquid Biopsy
13 Jul 2022 //
BUSINESSWIRE
Lucence Showcases Promising Data on ctDNA and ctRNA Liquid Biopsy Assay
31 May 2022 //
BUSINESSWIRE
Lucence to Publish Validation Study for LiquidHALLMARK ctDNA Liquid Biopsy Assay
19 May 2022 //
BUSINESSWIRE
Lucence, Yemaachi Launch AMBER Study for Genomic Alterations in Breast Cancer
26 Oct 2021 //
BUSINESSWIRE
Lucence`s Liquid Biopsy Detects Actionable Genomic Alterations in Bladder Cancer
13 Sep 2021 //
BUSINESSWIRE
Lucence Launches DeepMARK™ for Profiling of SARS-CoV-2 Subgenomic RNA
06 Oct 2020 //
BUSINESSWIRE
Lucence develops medical device for COVID-19 diagnosis
23 Mar 2020 //
BIOSPECTRUMASIA
Lucence Presents Data Demonstrating Potential of AmpliMARK
14 Jan 2020 //
BUSINESS WIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.